General Information of Drug (ID: DMYRPBI)

Drug Name
SR-4554 Drug Info
Synonyms CRC-94/17; N-(3,3,3-Trifluoro-2-hydroxypropyl)-2-(2-nitro-1-imidazolyl)acetamide
Indication
Disease Entry ICD 11 Status REF
Diagnostic imaging N.A. Phase 1 [1]
Cross-matching ID
PubChem CID
9882197
CAS Number
CAS 167648-73-9
TTD Drug ID
DMYRPBI

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Intracellular nitroreductase (INR) TT5XVD6 NOUNIPROTAC Modulator [2]

References

1 Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800007525)
2 A phase I study of SR-4554 via intravenous administration for noninvasive investigation of tumor hypoxia by magnetic resonance spectroscopy in patients with malignancy. Clin Cancer Res. 2003 Nov 1;9(14):5101-12.